http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2432179-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b55c349b43c3ecba4977fd52cc8f8c67 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
| filingDate | 2006-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be1f2a9d2b913687b51b5fba985193c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fabb9f5bd79eedbd3349a175fb7f5ec4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d84a9e2043fc2183a5dd778723e12c85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e3ac0ae41087b89a8bbc904f896a995 |
| publicationDate | 2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2432179-C2 |
| titleOfInvention | Absorption pharmaceutical preparation for percutaneous introduction |
| abstract | FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to cosmetics, particularly to antiperspirants. The invention is characterised by a stable absorption pharmaceutical preparation for percutaneous introduction of a primary medicine, with the exception of selegelin and selegelin hydrochloride which is exposed to reduced cohesive forces of an adhesive layer even in the presence of the sweat component because of transpiration and which is free from cohesive destruction and residual adhesive when the preparation is removed. The absorption pharmaceutical preparation for percutaneous introduction contains: a substrate; and an adhesive layer containing an adhesive, metal chloride and a skin-absorbable drug, with the exception of selegelin and selegelin hydrochloride where the adhesive layer is cross-linked. ^ EFFECT: improved efficacy of the preparation. ^ 8 cl, 18 ex |
| priorityDate | 2005-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.